Compounds > 3,3'-diindolylmethane
Page last updated: 2024-10-26

3,3'-diindolylmethane and Allergic Encephalomyelitis

3,3'-diindolylmethane has been researched along with Allergic Encephalomyelitis in 2 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rouse, M2
Singh, NP1
Nagarkatti, PS2
Nagarkatti, M2
Rao, R1

Other Studies

2 other studies available for 3,3'-diindolylmethane and Allergic Encephalomyelitis

ArticleYear
Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.
    British journal of pharmacology, 2013, Volume: 169, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Basic Helix-Loop-Helix Transcription Factors; Cell

2013
3,3'-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 350, Issue:2

    Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cells, Cultured; Core Binding Factor Alpha 2 Subunit; En

2014